Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| CFO | Evans Daron | Mar 30, 2026 | Buy | $28.5K | 10,000 |
| Chief Medical Officer | ROBERTS BRIAN KENNETH | Dec 16, 2025 | Buy | $47.6K | 28,000 |
| Director | Hogenhuis Wladimir | Dec 16, 2025 | Buy | $9.55K | 5,650 |
| CEO | Elam Nevan C | Dec 15, 2025 | Buy | $50.88K | 32,000 |
| CFO | Evans Daron | Dec 15, 2025 | Buy | $70.64K | 40,000 |
| Chief Commercial Officer | Karnawat Sunil Ratilal | Dec 15, 2025 | Buy | $19.44K | 12,000 |
| Chief Commercial Officer | Karnawat Sunil Ratilal | Dec 15, 2025 | Buy | $160 | 100 |
| CFO | Evans Daron | Dec 15, 2025 | Buy | $4.46K | 2,500 |
| CFO | Evans Daron | Dec 15, 2025 | Buy | $4.48K | 2,500 |
| CFO | Evans Daron | Dec 9, 2025 | Buy | $53.17K | 10,549 |
| Chief Medical Officer | ROBERTS BRIAN KENNETH | Jun 25, 2025 | Buy | $10.94K | 2,500 |
| CFO | Evans Daron | Jun 24, 2025 | Buy | $20.25K | 5,000 |
| Director | KREHER NERISSA | Jun 13, 2025 | Buy | $10K | 3,076 |
| Director | Kim Young-Jin | Jun 13, 2025 | Buy | $4M | 1,230,769 |
| Director | Hogenhuis Wladimir | Mar 31, 2025 | Buy | $19.73K | 6,758 |
| CEO | Elam Nevan C | Mar 27, 2025 | Buy | $35K | 12,302 |
| CFO | Evans Daron | Mar 26, 2025 | Buy | $28.9K | 10,000 |
| CFO | Evans Daron | Mar 26, 2025 | Buy | $28.8K | 10,000 |
| Director | Hogenhuis Wladimir | Feb 18, 2025 | Buy | $47K | 10,000 |
| CFO | Evans Daron | Dec 18, 2024 | Buy | $42.9K | 10,000 |
| CFO | Evans Daron | Dec 12, 2024 | Buy | $41.4K | 9,000 |
| Director | Hogenhuis Wladimir | Sep 24, 2024 | Buy | $20.02K | 4,259 |
| Director | Hogenhuis Wladimir | Jun 25, 2024 | Buy | $19.98K | 4,815 |
| Director | Kim Young-Jin | Jun 25, 2024 | Buy | $5M | 1,250,000 |
| Chief Medical Officer | ROBERTS BRIAN KENNETH | Jun 14, 2024 | Buy | $15.64K | 4,000 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.
